Navigation Links
New Parkinson's Treatment Shows Promise in Animals
Date:3/19/2009

Stimulation of spinal cord less invasive than deep brain stimulation, researchers say

THURSDAY, March 19 (HealthDay News) -- Rodents with Parkinson's-like symptoms walked and moved normally again after their spinal cords were stimulated with high frequency electrical currents, a new study shows.

Researchers said the technique, called dorsal column stimulation, has the potential to be an important new weapon in the arsenal against Parkinson's disease. Spinal cord stimulation could one day replace deep brain stimulation, an effective but highly invasive treatment of last resort for Parkinson's patients.

Researchers plan to begin testing the new technique on primates in a few months and, if successful, begin human testing in about a year.

"If this technology could work in humans, it would provide a completely new option for treating Parkinson's disease," said senior study investigator Dr. Miguel Nicolelis, a professor of neuroscience at Duke University Medical Center, in Durham, N.C.

The study appears in the March 20 issue of Science.

About 1.5 million Americans have Parkinson's disease, and another 60,000 are diagnosed each year, according to the National Parkinson Foundation. Parkinson's, which causes tremors, rigidity, slowed movements and a shuffling gait, is marked by a dying off of brain cells that produce the neurotransmitter dopamine.

Because Parkinson's is degenerative, symptoms can eventually include difficulty swallowing, smiling and speaking, as well as dementia.

During early stages of the disease, symptoms can usually be controlled using the medication levodopa, When combined with another drug, levodopa is converted into dopamine in the brain.

But as the disease progresses, the benefits from levodopa can diminish.

Patients with Parkinson's who are no longer responding well to medications sometimes turn to deep brain stimulation, in which electrodes are placed deep into areas of the brain and programmed to disrupt neurons that are firing incorrectly.

In many patients, blocking the abnormal nerve signals helps alleviate some of the movement problems.

Stimulating the spinal cord could be an improvement over deep brain stimulation because it's considered semi-invasive and the electrodes are easier to implant, Nicolelis said.

In the study, researchers implanted a device to stimulate the dorsal column of the rodents' spinal cords, which carry tactile signals to the brain. While the spinal cord stimulation did not rid the animals of all symptoms, the rodents were able to take 80 percent less medicine.

"We see an almost immediate and dramatic change in the animal's ability to function," Nicolelis said.

Dr. Michael Okun, national medical director of the National Parkinson Foundation, said the results were "interesting."

"Although the observations are preliminary, they are intriguing given our current difficulty in treating dopamine-resistant gait disorders in human sufferers of the disease," Okun said. "More research will be required to confirm these effects before moving into human trials."

For now, deep brain stimulation remains one of the last options for Parkinson's patients. About 71 percent of patients who underwent the procedure experienced an improvement in symptoms, according to a study published in January in the Journal of the American Medical Association.

Doctors don't know precisely why the electrical stimulation works, though a study in the March 19 online issue of Science Express provides some clues.

Researchers from Stanford used a technique called "optogenetics" to study neural circuits in the brain. They found that in rodents with dopamine deficiencies, stimulating the neural wires called axons that converge in the subthalmic nucleas region of the brain had a greater effect on improving Parkinson's symptoms than stimulating the cells in that region of the brain itself.

Because the axons lie closer to the surface of the brain, it's possible the discovery will lead to new, less invasive techniques, researchers said.

"Because these axons are coming from areas closer to the brain's surface, new treatments could perhaps be less invasive than deep brain stimulation," said Dr. Karl Deisseroth, senior study author and an associate professor of bioengineering, psychiatry and behavioral sciences at Stanford University.

More information

The National Parkinson Foundation has more about symptoms and treatments for the disease.



SOURCES: Miguel Nicolelis, M.D., Ph.D., professor, neuroscience, Duke University Medical Center, Durham, N.C.; Michael Okun, M.D., national medical director, National Parkinson Foundation; March 19, 2009, Science Express, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. New treatment boosts muscle function in myasthenia gravis
3. Broad-based group of physicians calls for improvement in stroke treatment
4. Cranberry Could Juice Up Ovarian Cancer Treatment
5. Non-medicinal treatment touted for pre-schoolers with ADHD
6. Nonmedicinal treatment touted for preschoolers with ADHD
7. U of M study: Early treatment can reverse heart damage
8. Biologic treatment for rheumatoid arthritis and the risk of cancer
9. New Treatment Explored for Cluster Headaches
10. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
11. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Parkinson's Treatment Shows Promise in Animals
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: